news

/news

KLOX Technologies reports on final results from its clinical study on LumiHeal™ for the treatment of chronic wounds

By | 2017-11-02T22:43:16-04:00 May 3rd, 2017|

Laval, Quebec, May 3rd, 2017 (GLOBE NEWSWIRE) - Today, the final results on KLOX Technologies’ (Klox) EUREKA study, which evaluated LumiHeal in the treatment of hard-to-heal, non-responsive, chronic wounds, were reported at the European Wound Management Association, in Amsterdam. LumiHeal is a CE marked, first-in-class, proprietary, non-thermal and non-invasive treatment solution that utilizes hyper pulsed [...]

Klox Technologies and LEO Pharma set up company for BioPhotonic in dermatology

By | 2017-11-07T19:55:20-05:00 March 6th, 2017|

Laval, Québec, Canada, and Ballerup, Denmark March 6th. Klox Technologies Inc. (‘Klox’) and LEO Pharma A/S (‘LEO Pharma’) to establish a jointly owned company to further develop and commercialize Klox’s BioPhotonic technology in dermatology including Kleresca® for acne and Kleresca® for skin rejuvenation. Both companies bring in their contributions from their existing collaboration which started in [...]

KLOX Technologies reports on its interim results from its ongoing clinical studies on LumiHeal™ for the treatment of chronic wounds and postsurgical scarring

By | 2017-11-07T19:55:52-05:00 September 28th, 2016|

Data presented at the 2016 World Union of Wound Healing Societies Congress LAVAL, Quebec, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Today, clinical interim results on KLOX Technologies (Klox) LumiHealTM for the treatment of hard-to-heal non-responsive chronic wounds and postsurgical scarring will be reported in conjunction with the 2016 World Union of Wound Healing Societies (WUWHS) Congress [...]